ARTICLE

FindCenter AddIcon

Ketamine for Depression Still Too Expensive for Widespread Use

By Technology Networks — 2020

A paper authored by researchers from McLean Hospital has determined that esketamine, a nasal spray to treat severe depression, is currently too expensive for widespread use. The study compared the costs and benefits of esketamine, an antidepressant approved by the U.S. Food and Drug Administration (FDA) last year for use in treatment-resistant major depressive disorder.

Read on www.technologynetworks.com

FindCenter Post-Image

How Do I Know If My Child with Autism Is Depressed?

According to research, approximately 20 percent of the population will experience depression at some point in their lives—this statistic increases to almost 60 percent in people with autism spectrum disorder (ASD).

FindCenter AddIcon
FindCenter Post-Image

Evaluating the Effects of Medication

When a medication is being evaluated to modify the behavior of a person with autism, one must assess the risks versus the benefits.

FindCenter AddIcon

EXPLORE TOPIC

Clinical Depression